Andrew B Lassman

Andrew B Lassman

UNVERIFIED PROFILE

Are you Andrew B Lassman?   Register this Author

Register author
Andrew B Lassman

Andrew B Lassman

Publications by authors named "Andrew B Lassman"

Are you Andrew B Lassman?   Register this Author

100Publications

2441Reads

40Profile Views

A Phase Ib/II, open-label, multicenter study of INC280 (capmatinib) alone and in combination with buparlisib (BKM120) in adult patients with recurrent glioblastoma.

J Neurooncol 2019 Nov 27. Epub 2019 Nov 27.

Clinical Cooperation Unit Neurooncology, German Cancer Consortium (DKTK), German Cancer Research Center (DKFZ), and Neurology Clinic and National Center for Tumor Diseases, University Hospital Heidelberg, Heidelberg, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s11060-019-03337-2DOI Listing
November 2019

Phase II trial of an AKT inhibitor (perifosine) for recurrent glioblastoma.

J Neurooncol 2019 Sep 19;144(2):403-407. Epub 2019 Jul 19.

Department of Neurology, Memorial Sloan Kettering Cancer Center, New York, NY, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s11060-019-03243-7DOI Listing
September 2019

Magnetic Resonance Imaging-Based Screening for Asymptomatic Brain Tumors: A Review.

Oncologist 2019 03 10;24(3):375-384. Epub 2018 Oct 10.

Department of Neurological Surgery, Weill-Cornell Medical College, New York New York, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1634/theoncologist.2018-0177DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6519753PMC
March 2019

Chemotherapy Treatment and Trials in Low-Grade Gliomas.

Neurosurg Clin N Am 2019 Jan;30(1):103-109

Department of Neurology and Herbert Irving Cancer Comprehensive Cancer Center, Columbia University Irving Medical Center, NewYork-Presbyterian Hospital, 710 West 168th Street, New York, NY 10032, USA. Electronic address:

View Article

Download full-text PDF

Source
https://linkinghub.elsevier.com/retrieve/pii/S10423680183088
Publisher Site
http://dx.doi.org/10.1016/j.nec.2018.08.007DOI Listing
January 2019

Clinical Reasoning: Transient speech deficits in a patient with history of medulloblastoma.

Neurology 2018 09;91(12):e1196-e1201

From the Departments of Neurology (J.D.S., A.B.L.), Pathology and Cell Biology (G.H., P.C.), Neurological Surgery (M.B.S.), Radiation Oncology (T.J.C.W.), and Radiology (A.L.), and the Herbert Irving Comprehensive Cancer Center (P.C., M.B.S., T.J.C.W., A.B.L.), Columbia University Irving Medical Center, New York, NY.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1212/WNL.0000000000006202DOI Listing
September 2018

Clinical and molecular characteristics of gliosarcoma and modern prognostic significance relative to conventional glioblastoma.

J Neurooncol 2018 Apr 20;137(2):303-311. Epub 2017 Dec 20.

Department of Radiation Oncology, Columbia University Medical Center, 622 West 168th Street, CHONY North B11, New York, NY, 10032, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s11060-017-2718-zDOI Listing
April 2018

Local control and overall survival for adjuvant stereotactic radiosurgery in patients with residual or recurrent disease.

J Neurooncol 2018 Jan 23;136(2):281-287. Epub 2017 Nov 23.

Department of Radiation Oncology, Columbia University Medical Center, 622 West 168th Street, BNH B-11, New York, NY, 10032, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s11060-017-2651-1DOI Listing
January 2018

Antibody-drug conjugates in glioblastoma therapy: the right drugs to the right cells.

Nat Rev Clin Oncol 2017 Nov 4;14(11):695-707. Epub 2017 Jul 4.

Austin Health and Olivia Newton-John Cancer Research Institute, 145 Studley Road, Heidelberg, Victoria 3084, Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/nrclinonc.2017.95DOI Listing
November 2017

Comparing sequencing assays and human-machine analyses in actionable genomics for glioblastoma.

Neurol Genet 2017 Aug 11;3(4):e164. Epub 2017 Jul 11.

New York Genome Center (K.O.W., M.O.F., N.R., A.-K.E., B.-J.C., K.A., M.S., V.V., E.A.B., J.L.M.V., M.C.Z., V.J., R.B.D.); IBM Thomas J. Watson Research Center (T.K., K.R., F.U., R.N., E.B., L.P., A.K.R.); Columbia University Medical Center (J.N.B., A.B.L., P.C., V.J.); Memorial Sloan-Kettering Cancer Center (C.G.), New York, NY; IBM Watson Health (S.H., V.V.M.), Boca Raton, FL; Laboratory of Molecular Neuro-Oncology (M.O.F., R.B.D.), and Howard Hughes Medical Institute (R.B.D.), The Rockefeller University, New York, NY. B.-J.C. is currently affiliated with Google, New York, NY. V.V. is currently affiliated with 23andMe, Inc., Mountain View, CA. E.A.B. is currently affiliated with Max Planck Institute of Immunobiology and Epigenetics, Freiburg, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1212/NXG.0000000000000164DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5506390PMC
August 2017

Efficacy and safety results of ABT-414 in combination with radiation and temozolomide in newly diagnosed glioblastoma.

Neuro Oncol 2017 Jul;19(7):965-975

Center for Neuro-Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts; Department of Neurology & Herbert Irving Comprehensive Cancer Center, Columbia University Medical Center, New York, New York; Neuro-Oncology Unit, Erasmus MC Cancer Center, Rotterdam, the Netherlands; Department of Neurology, Northwestern University, Chicago, Illinois; Department of Neurology, NorthShore University HealthSystem, Evanston, Illinois; Department of Medical Oncology, Austin Health and Olivia Newton-John Cancer Research Institute, Melbourne, Victoria, Australia; School of Cancer Medicine, La Trobe University School of Cancer Medicine, Melbourne, Victoria, Australia; South Texas Accelerated Research Therapeutics (START), San Antonio, Texas; Department of Radiation Oncology, The University of Texas M.D.Anderson Cancer Center, Houston, Texas; AbbVie Inc., North Chicago, Illinois; Department of Medicine, University of Melbourne, Melbourne, Victoria, Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/neuonc/now257DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5570193PMC
July 2017

NovoTTF: where to go from here?

Neuro Oncol 2017 05;19(5):605-608

Department of Neurology and Herbert Irving Comprehensive Cancer Center, Columbia University Medical Center, New York, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/neuonc/nox014DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5464445PMC
May 2017

Biomarkers in NOA-04: another piece to the puzzle.

Neuro Oncol 2016 11;18(11):1467-1469

Department of Neurology and Herbert Irving Comprehensive Cancer Center, Columbia University Medical Center, New York, New York (A.B.L.); Neuro-Oncology Program and Department of Neurology, David Geffen School of Medicine, University of California Los Angeles, Los Angeles, California (T.F.C.).

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/neuonc/now210DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5063524PMC
November 2016

Procarbazine, lomustine and vincristine or temozolomide: which is the better regimen?

Authors:
Andrew B Lassman

CNS Oncol 2015 6;4(5):341-6. Epub 2015 Nov 6.

Department of Neurology & Herbert Irving Comprehensive, Cancer Center, Columbia University Medical Center, 710 West 168th Street, NY, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.2217/cns.15.36DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6082332PMC
August 2016

Timing of Adjuvant Radiotherapy in Glioblastoma Patients: A Single-Institution Experience With More Than 400 Patients.

Neurosurgery 2016 May;78(5):676-82

*Department of Radiation Oncology, Columbia University Medical Center, New York, New York;‡Herbert Irving Comprehensive Cancer Center, Columbia University Medical Center, New York, New York;§Department of Neurological Surgery, Columbia University Medical Center, New York, New York;¶Department of Radiology, Columbia University Medical Center, New York, New York;‖The Taub Institute for Research on Alzheimer's Disease and the Aging Brain, Columbia University Medical Center, New York, New York;#Division of Pediatric Hematology/Oncology and Stem Cell Transplantation, Department of Pediatrics, Columbia University Medical Center, New York, New York;**Department of Neurology, Columbia University Medical Center, New York, New York.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1227/NEU.0000000000001036DOI Listing
May 2016

A Modern Radiotherapy Series of Survival in Hispanic Patients with Glioblastoma.

World Neurosurg 2016 Apr 31;88:260-269. Epub 2015 Dec 31.

Herbert Irving Comprehensive Cancer Center, Columbia University Medical Center, New York, New York, USA; Department of Neurological Surgery, Columbia University Medical Center, New York, New York, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.wneu.2015.12.081DOI Listing
April 2016

Clinical Cancer Advances 2016: Annual Report on Progress Against Cancer From the American Society of Clinical Oncology.

J Clin Oncol 2016 Mar 4;34(9):987-1011. Epub 2016 Feb 4.

Don S. Dizon, Massachusetts General Hospital, Boston; Erica Mayer, Dana-Farber Cancer Institute, Boston, MA; Lada Krilov and Richard Schilsky, American Society of Clinical Oncology, Alexandria, VA; Ezra Cohen, University of California San Diego, San Diego; Patricia A. Ganz, University of California Los Angeles, Los Angeles; Sumanta Kumar Pal, City of Hope Comprehensive Cancer Center, Duarte, CA; Tara Gangadhar, University of Pennsylvania; Stephen Hunger, Children's Hospital Center of Philadelphia, Philadelphia, PA; Thomas A. Hensing, University of Chicago, Evanston, IL; Smitha S. Krishnamurthi, Case Western Reserve University, Cleveland, OH; Andrew B. Lassman and Gary K. Schwartz, Columbia University; David R. Spriggs, Memorial Sloan Kettering Cancer Center; Gina Villani, Ralph Lauren Center for Cancer Care and Prevention, New York, NY; Merry Jennifer Markham, University of Florida, Gainesville; Miguel Angel Villalona-Calero, Miami Cancer Institute, Miami, FL; Michael Neuss, Vanderbilt-Ingram Cancer Center, Nashville, TN; Lisa C. Richardson, Centers for Disease Control and Prevention, Atlanta, GA; and Gregory Masters, Helen F. Graham Cancer Center and Research Institute, Newark, DE.

View Article

Download full-text PDF

Source
http://news.medlive.cn/uploadfile/20160205/14546422512856.pd
Web Search
http://jco.ascopubs.org/cgi/doi/10.1200/JCO.2015.65.8427
Publisher Site
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5075244PMC
http://dx.doi.org/10.1200/JCO.2015.65.8427DOI Listing
March 2016

Control of brain metastases from radioresistant tumors treated by stereotactic radiosurgery.

J Neurooncol 2015 Sep 2;124(3):507-14. Epub 2015 Aug 2.

Department of Radiation Oncology, Columbia University Medical Center, 622 West 168th Street, BNH B-11, New York, NY, 10032, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s11060-015-1871-5DOI Listing
September 2015

Phase 2 trial of dasatinib in target-selected patients with recurrent glioblastoma (RTOG 0627).

Neuro Oncol 2015 Jul 10;17(7):992-8. Epub 2015 Mar 10.

Department of Neurology and Herbert Irving Comprehensive Cancer Center, Columbia University Medical Center, New York, New York (A.B.L. current); Memorial Sloan Kettering Cancer Center, New York, New York (A.B.L. during accrual, L.M.D.); NRG Oncology Statistics and Data Management Center, Philadelphia, Pennsylvania (S.L.P., S.G., M.W); The University of Texas MD Anderson Cancer Center, Houston, Texas (M.R.G., K.D.A. during accrual; R.K.); Neuro-Oncology Branch, National Cancer Institute/National Institute of Neurological Disorders and Stroke, National Institutes of Health, Bethesda, Maryland (M.R.G. current); University of Toronto and Princess Margaret Cancer Centre, Toronto, Canada (K.D.A. current); Cancer Therapeutics Program, University of Pittsburgh Cancer Institute, Pittsburgh, Pennsylvania (J.H.B., S.M.C.); Department of Pharmaceutical Sciences, University of Pittsburgh School of Pharmacy Pittsburgh, Pennsylvania (J.H.B.); NCI Community Oncology Research Program - Kansas City, Prairie Village, Kansas (R.G.); Arizona Oncology Services Foundation, Tucson, Arizona (E.Y.); Penn State University and The Milton S. Hershey Medical Center, Hershey, Pennsylvania (H.W.); University of Maryland Medical Systems, Baltimore, Maryland (M.P.M.).

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/neuonc/nov011DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5762006PMC
July 2015

The Energy Index Does Not Affect Local Control of Brain Metastases Treated by Gamma Knife Stereotactic Radiosurgery.

Neurosurgery 2015 Jul;77(1):119-25; discussion 125

‡Department of Radiation Oncology, §The Taub Institute for Research on Alzheimer's Disease and the Aging Brain, ¶Herbert Irving Comprehensive Cancer, ‖Department of Neurological Surgery, and #Department of Neurology, Columbia University Medical Center, New York, New York.

View Article

Download full-text PDF

Source
https://academic.oup.com/neurosurgery/article-lookup/doi/10.
Publisher Site
http://dx.doi.org/10.1227/NEU.0000000000000750DOI Listing
July 2015

Does lung cancer mutation status and targeted therapy predict for outcomes and local control in the setting of brain metastases treated with radiation?

Neuro Oncol 2015 Jul 24;17(7):1022-8. Epub 2015 Apr 24.

Department of Radiation Oncology (T.J.C.W., S.S., A.J., T.N., A.M.Y., T.R., J.L., S.K.C., S.R.I.); Herbert Irving Comprehensive Cancer Center (T.J.C.W., M.B.Si., J.N.B., G.M.M., B.H., M.B.St., A.B.L., S.K.C., S.R.I.); The Taub Institute for Research on Alzheimer's Disease and the Aging Brain (Y.H.Q.); Department of Neurological Surgery (M.B.Si., J.N.B., G.M.M.); Department of Neurology (A.B.L.); and Division of Hematology/Oncology (B.H., M.B.St.), Columbia University Medical Center, New York, New York.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/neuonc/nov043DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5762012PMC
July 2015

Indications for Treatment: Is Observation or Chemotherapy Alone a Reasonable Approach in the Management of Low-Grade Gliomas?

Semin Radiat Oncol 2015 Jul 23;25(3):203-9. Epub 2015 Feb 23.

Department of Neurology, New York-Presbyterian/Columbia University Medical Center, New York, NY; Herbert Irving Comprehensive Cancer Center, Columbia University Medical Center, New York, NY. Electronic address:

View Article

Download full-text PDF

Source
https://linkinghub.elsevier.com/retrieve/pii/S10534296150002
Publisher Site
http://dx.doi.org/10.1016/j.semradonc.2015.02.008DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4562771PMC
July 2015

Opsoclonus-myoclonus syndrome in a patient with an anaplastic oligoastrocytoma.

J Neurooncol 2015 Jun 12;123(2):315-6. Epub 2015 Apr 12.

Department of Neurology (C.A.G, A.B.L., Y.O.) and Herbert Irving Comprehensive Cancer Center (A.B.L., Y.O.), New York-Presbyterian Hospital/Columbia University Medical Center, New York, NY, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s11060-015-1783-4DOI Listing
June 2015

Radiotherapy and temozolomide for anaplastic astrocytic gliomas.

J Neurooncol 2015 May 29;123(1):129-34. Epub 2015 Apr 29.

Department of Neurology, Memorial Sloan Kettering Cancer Center, New York, NY, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s11060-015-1771-8DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4606458PMC
May 2015

Factorial clinical trials: a new approach to phase II neuro-oncology studies.

Neuro Oncol 2015 Feb 1;17(2):174-6. Epub 2014 Dec 1.

Department of Neurology and Herbert Irving Comprehensive Cancer Center, Columbia University Medical Center.

View Article

Download full-text PDF

Source
https://academic.oup.com/neuro-oncology/article-lookup/doi/1
Publisher Site
http://dx.doi.org/10.1093/neuonc/nou314DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4288526PMC
February 2015

Phase II trial of sunitinib for recurrent and progressive atypical and anaplastic meningioma.

Neuro Oncol 2015 Jan 6;17(1):116-21. Epub 2014 Aug 6.

Department of Neurology, Memorial Sloan Kettering Cancer Center, New York, New York (T.J.K., S.K., A.B.L., C.P.N., L.M.D., I.G., L.E.A., A.O.); Center for Neuro-Oncology, Dana-Farber Cancer Institute/Brigham and Women's Center, Boston, Massachusetts (P.W., K.L., S.H., A.N., J.D., E.Q.L.); Department of Neurology, University of Virginia, Charlottesville, Virginia (D.S., B.P.); Department of Neurology, Massachusetts General Hospital, Boston, Massachusetts (S.R.P., T.B.).

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/neuonc/nou148DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4483051PMC
January 2015

Recursive partitioning analysis of prognostic variables in newly diagnosed anaplastic oligodendroglial tumors.

Neuro Oncol 2014 Nov 4;16(11):1541-6. Epub 2014 Jul 4.

Departments of Neurology (A.B.L., F.M.I., L.E.A., L.M.D.), Pathology (S.C.J., M.K.R.), Epidemiology & Biostatistics (A.S.R., K.S.P.), and the Brain Tumor Center, Memorial Sloan-Kettering Cancer Center, New York, New York; University of California, Los Angeles, Los Angeles, California (T.F.C.); Department of Pathology, The University of Texas MD Anderson Cancer Center, Houston, Texas (K.D.A., A.L.R.); Massachusetts General Hospital and Harvard Medical School, Boston, Massachusetts (A.F.E., D.N.L.); NorthShore University Health System, Evanston Hospital Kellogg Cancer Center, University of Chicago, Pritzker School of Medicine, Evanston, Illinois (N.A.P.); London Regional Cancer Program, London, Ontario, Canada (B.J.F.); Barrow Neurological Institute, Phoenix, Arizona (L.S.A.); University of Calgary, Calgary, Alberta, Canada (J.G.C., G.B.R.U.); Brigham and Women's Hospital and Dana-Farber Cancer Institute, Boston, Massachusetts (P.Y.W.); Center for Molecular Oncologic Pathology, Dana-Farber Cancer Institute, Children's Hospital Boston, Brigham and Women's Hospital, Boston, Massachusetts (K.L.L.); University of Virginia Health System, Charlottesville, Virginia (D.S.); University of Wisconsin, Madison, Wisconsin (H.I.R., B.G.R.); University of Washington, Fred Hutchinson Cancer Research Center and Seattle Cancer Care Alliance, Seattle, Washington (M.C.C.); Princess Margaret Hospital, Toronto, Ontario, Canada (W.P.M.); Albany Medical Center, Albany, New York (S.A.W.); Kaiser Permanente-Los Angeles Medical Center, Los Angeles, California (R.M.G.); Clemenceau Medical Center, Beirut, Lebanon and Université Saint-Esprit de Kaslik, Byblos, Lebanon (F.G.K.).

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/neuonc/nou083DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4201067PMC
November 2014

Fetal radiation monitoring and dose minimization during intensity modulated radiation therapy for glioblastoma in pregnancy.

J Neurooncol 2014 Nov 6;120(2):405-9. Epub 2014 Aug 6.

Department of Radiation Oncology, Columbia University College of Physicians and Surgeons, New York, NY, 10032, USA,

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s11060-014-1565-4DOI Listing
November 2014

Steroid management in newly diagnosed glioblastoma.

J Neurooncol 2013 May 6;113(1):111-6. Epub 2013 Mar 6.

Department of Neurology, Memorial Sloan-Kettering Cancer Center, 1275 York Avenue, New York, NY 10065, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s11060-013-1096-4DOI Listing
May 2013

Oligodendrogliomas: questions answered, answers questioned.

Authors:
Andrew B Lassman

Oncology (Williston Park) 2013 Apr;27(4):326, 328

Department of Neurology and the Herbert Irving Comprehensive Cancer Center, NewYork-Presbyterian/Columbia University Medical Center, New York, New York, USA.

View Article

Download full-text PDF

Source
April 2013

Patterns of failure after concurrent bevacizumab and hypofractionated stereotactic radiation therapy for recurrent high-grade glioma.

Int J Radiat Oncol Biol Phys 2013 Mar 3;85(3):636-42. Epub 2012 Jul 3.

Department of Radiation Oncology, Memorial Sloan-Kettering Cancer Center, New York, New York, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ijrobp.2012.05.031DOI Listing
March 2013

Success at last: a molecular factor that informs treatment.

Authors:
Andrew B Lassman

Curr Oncol Rep 2013 Feb;15(1):47-55

Department of Neurology and Herbert Irving Comprehensive Cancer Center, Columbia University Medical Center, New York, NY 10538, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s11912-012-0281-5DOI Listing
February 2013

Abbreviated course of radiation therapy with concurrent temozolomide for high-grade glioma in patients of advanced age or poor functional status.

J Neurooncol 2012 Dec 16;110(3):369-74. Epub 2012 Sep 16.

Department of Radiation Oncology, Memorial Sloan-Kettering Cancer Center, 1275 York Avenue, New York, NY 10065, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s11060-012-0972-7DOI Listing
December 2012

Bevacizumab for glioblastoma refractory to vascular endothelial growth factor receptor inhibitors.

J Neurooncol 2012 Apr 28;107(2):407-11. Epub 2011 Dec 28.

Department of Neurology and the Brain Tumor Center, Memorial Sloan-Kettering Cancer Center, New York, NY, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s11060-011-0768-1DOI Listing
April 2012

Cilengitide in patients with recurrent glioblastoma: the results of NABTC 03-02, a phase II trial with measures of treatment delivery.

J Neurooncol 2012 Jan 8;106(1):147-53. Epub 2011 Jul 8.

Department of Neuro-oncology, M. D. Anderson Cancer Center, The University of Texas, 1515 Holcombe Blvd, Houston, TX 77030, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s11060-011-0650-1DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4351869PMC
January 2012

"Pulsatile" high-dose weekly erlotinib for CNS metastases from EGFR mutant non-small cell lung cancer.

Neuro Oncol 2011 Dec 24;13(12):1364-9. Epub 2011 Aug 24.

Department of Neurology, Memorial Sloan-Kettering Cancer Center, 1275 York Avenue, New York, NY 10065, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/neuonc/nor121DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3223088PMC
December 2011

Signal transduction inhibitors and antiangiogenic therapies for malignant glioma.

Glia 2011 Aug 23;59(8):1205-12. Epub 2011 Feb 23.

Human Oncology and Pathogenesis Program, Memorial Sloan-Kettering Cancer Center, New York, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/glia.21137DOI Listing
August 2011

High dose weekly erlotinib achieves therapeutic concentrations in CSF and is effective in leptomeningeal metastases from epidermal growth factor receptor mutant lung cancer.

J Neurooncol 2010 Sep 10;99(2):283-6. Epub 2010 Feb 10.

Department of Neurology and Brain Tumor Center, Memorial Sloan-Kettering Cancer Center, 1275 York Avenue, New York, NY 10065, USA.

View Article

Download full-text PDF

Source
http://link.springer.com/10.1007/s11060-010-0128-6
Publisher Site
http://dx.doi.org/10.1007/s11060-010-0128-6DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3973736PMC
September 2010

Molecular markers in gliomas: impact for the clinician.

Target Oncol 2010 Sep 31;5(3):201-10. Epub 2010 Aug 31.

Department of Oncology, University Hospital Zürich, Zürich, Switzerland.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s11523-010-0157-2DOI Listing
September 2010

Paraneoplastic opsoclonus-myoclonus syndrome secondary to immature ovarian teratoma.

Gynecol Oncol 2010 May 7;117(2):382-4. Epub 2010 Feb 7.

Department of Medicine, Memorial Sloan-Kettering Cancer Center, New York, NY, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ygyno.2010.01.017DOI Listing
May 2010

Advances in the treatment of malignant gliomas.

Curr Oncol Rep 2010 Jan;12(1):26-33

Department of Neurology and Brain Tumor Center, Memorial Sloan-Kettering Cancer Center, 1275 York Avenue, New York, NY 10065, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s11912-009-0077-4DOI Listing
January 2010

Therapeutic advances in malignant glioma: current status and future prospects.

Neuroimaging Clin N Am 2009 Nov;19(4):647-56

Department of Medicine, University of Wisconsin School of Medicine and Public Health, Madison, WI 53792, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.nic.2009.08.015DOI Listing
November 2009

A pilot study of everolimus and gefitinib in the treatment of recurrent glioblastoma (GBM).

J Neurooncol 2009 Mar 19;92(1):99-105. Epub 2008 Nov 19.

Neuro-Oncology Branch, National Cancer Institute, 9030 Old Georgetown Road, Bethesda, MD 20892, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s11060-008-9741-zDOI Listing
March 2009

Molecular profiling of oligodendrogliomas: impact on prognosis, treatment, and future directions.

Curr Oncol Rep 2009 Jan;11(1):62-7

Department of Neurology, Memorial Sloan-Kettering Cancer Center, New York, NY 10065, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s11912-009-0010-xDOI Listing
January 2009

A phase II trial of vinorelbine and intensive temozolomide for patients with recurrent or progressive brain metastases.

J Neurooncol 2008 Mar 7;87(1):85-90. Epub 2007 Nov 7.

Department of Neurology, Memorial Sloan-Kettering Cancer Center, New York, NY, 10021, USA.

View Article

Download full-text PDF

Source
http://link.springer.com/10.1007/s11060-007-9491-3
Publisher Site
http://dx.doi.org/10.1007/s11060-007-9491-3DOI Listing
March 2008

Incorporating molecular tools into clinical trials and treatment for gliomas?

Curr Opin Neurol 2007 Dec;20(6):708-11

Department of Neurology, Memorial Sloan-Kettering Cancer Center, New York, NY 10065, USA.

View Article

Download full-text PDF

Source
https://insights.ovid.com/crossref?an=00019052-200712000-000
Publisher Site
http://dx.doi.org/10.1097/WCO.0b013e3282f1a05cDOI Listing
December 2007

Myelosuppression in patients benefiting from imatinib with hydroxyurea for recurrent malignant gliomas.

J Neurooncol 2007 Nov 27;85(2):217-22. Epub 2007 Jun 27.

Department of Neurology, Memorial Sloan-Kettering Cancer Center, 1275 York Avenue, New York, NY 10021, USA

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s11060-007-9408-1DOI Listing
November 2007

Should patients with anaplastic oligodendroglial tumors receive adjuvant chemotherapy?

Nat Clin Pract Oncol 2007 Feb 16;4(2):78-9. Epub 2007 Jan 16.

Memorial Sloan-Kettering Cancer Center, New York, NY 10021, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/ncponc0690DOI Listing
February 2007

Glioma oncogenesis and animal models of glioma formation.

Hematol Oncol Clin North Am 2006 Dec;20(6):1193-214

Department of Cancer Biology, Memorial Sloan-Kettering Cancer Center, 408 East 69th Street, Z1319, New York, NY 10021, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.hoc.2006.09.005DOI Listing
December 2006

Metastases to the pineal gland.

Neurology 2006 Oct;67(7):1303-4

Department of Neurology, Memorial Sloan-Kettering Cancer Center, New York, NY 10021, USA.

View Article

Download full-text PDF

Source
http://www.neurology.org/cgi/doi/10.1212/01.wnl.0000238516.2
Publisher Site
http://dx.doi.org/10.1212/01.wnl.0000238516.29603.33DOI Listing
October 2006

Systemic high-dose intravenous methotrexate for central nervous system metastases.

J Neurooncol 2006 Jul;78(3):255-60

Department of Neurology, Memorial Sloan-Kettering Cancer Center, New York, NY, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s11060-005-9044-6DOI Listing
July 2006

Unraveling molecular markers of biologic therapies in glioma.

Curr Neurol Neurosci Rep 2006 May;6(3):185-6

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s11910-006-0003-1DOI Listing
May 2006

Response of glioblastomas to EGFR kinase inhibitors.

N Engl J Med 2006 Feb;354(5):525-6; author reply 525-6

View Article

Download full-text PDF

Source
http://www.nejm.org/doi/abs/10.1056/NEJMc053459
Publisher Site
http://dx.doi.org/10.1056/NEJMc053459DOI Listing
February 2006

Salvage temozolomide for prior temozolomide responders.

Cancer 2005 Dec;104(11):2473-6

Department of Medical Oncology, Bellaria Hospital, Bologna, Italy.

View Article

Download full-text PDF

Source
http://doi.wiley.com/10.1002/cncr.21564
Publisher Site
http://dx.doi.org/10.1002/cncr.21564DOI Listing
December 2005

Paroxysmal apnea and vasomotor instability following medullary infarction.

Arch Neurol 2005 Aug;62(8):1286-8

Department of Neurology, Memorial Sloan-Kettering Cancer Center, New York, NY, USA.

View Article

Download full-text PDF

Source
http://archneur.jamanetwork.com/article.aspx?doi=10.1001/arc
Publisher Site
http://dx.doi.org/10.1001/archneur.62.8.1286DOI Listing
August 2005

Molecular biology of gliomas.

Authors:
Andrew B Lassman

Curr Neurol Neurosci Rep 2004 May;4(3):228-33

Department of Neurology, Memorial Sloan-Kettering Cancer Center, 1275 York Avenue, New York, NY 10021, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s11910-004-0043-3DOI Listing
May 2004

Brain metastases.

Neurol Clin 2003 Feb;21(1):1-23, vii

Department of Neurology, Memorial Sloan-Kettering Cancer Center, New York, New York, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/s0733-8619(02)00035-xDOI Listing
February 2003